Search Results

Reply: NAFLD - there ain't no such thing as a free lunch.

• Authors : Lazarus JV; CUNY Graduate School of Public Health and Health Policy (CUNY SPH), New York, NY, USA.; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.

• Source: Hepatology (Baltimore, Md.) [Hepatology] 2024 Mar 13. Date of Electronic Publication: 2024 Mar 13.Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 8302946 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Steatotic liver disease: a new name to reflect the combined role of alcohol and metabolic dysfunction.

• Authors : Krag A; Centre for Liver Research, Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark. .; Institute of Clinical Research, University of Southern Denmark, Odense, Denmark. .

• Source: Nature medicine [Nat Med] 2024 Mar 08. Date of Electronic Publication: 2024 Mar 08.Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study.

• Authors : Israelsen M; GALAXY consortium

Subjects: Fatty Liver* ; Gastroenterology*; Humans

• Source: The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2024 Mar; Vol. 9 (3), pp. 218-228. Date of Electronic Publication: 2024 Jan 11.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101690683 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Reply: A multi-society Delphi consensus statement on new fatty liver disease nomenclature.

• Authors : Lazarus JV; CUNY Graduate School of Public Health and Health Policy (CUNY SPH), New York, New York, USA.; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.

Subjects: Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/diagnosis; Humans ; Delphi Technique

• Source: Hepatology (Baltimore, Md.) [Hepatology] 2024 Mar 01; Vol. 79 (3), pp. E93-E94. Date of Electronic Publication: 2023 Nov 20.Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 8302946 Publication Model: Print-Electronic Cited Medium: Internet

Record details

A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis.

• Authors : Rinella ME; University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA.; Lieu HD

Subjects: Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/complications ; Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/drug therapy ; Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/pathology

• Source: Hepatology (Baltimore, Md.) [Hepatology] 2024 Mar 01; Vol. 79 (3), pp. 674-689. Date of Electronic Publication: 2023 Sep 21.Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 8302946 Publication Model: Print-Electronic Cited Medium: Internet

Record details

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.

• Authors : Harrison SA; MAESTRO-NASH Investigators

Subjects: Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/drug therapy ; Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/etiology ; Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/pathology

• Source: The New England journal of medicine [N Engl J Med] 2024 Feb 08; Vol. 390 (6), pp. 497-509.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement.

• Authors : Hagström H; Department of Upper GI, Division of Hepatology, Karolinska University Hospital, Stockholm, Sweden.; Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.

Subjects: International Classification of Diseases* ; Liver Diseases*; Humans

• Source: Hepatology communications [Hepatol Commun] 2024 Feb 03; Vol. 8 (2). Date of Electronic Publication: 2024 Feb 03 (Print Publication: 2024).Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101695860 Publication Model: eCollection Cited Medium: Internet

Record details

Reply: 'From NAFLD to MASLD: Promise and pitfalls of a new definition' †.

• Authors : Rinella ME; University of Chicago, Pritzker School of Medicine, Chicago, Illinois, USA.; Castro Narro GE

Subjects: Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/diagnosis; Humans

• Source: Hepatology (Baltimore, Md.) [Hepatology] 2024 Feb 01; Vol. 79 (2), pp. E16-E17. Date of Electronic Publication: 2023 Dec 19.Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 8302946 Publication Model: Print-Electronic Cited Medium: Internet

Record details

A global action agenda for turning the tide on fatty liver disease.

• Authors : Lazarus JV; on behalf of the Healthy Livers, Healthy Lives Collaborators

Subjects: Delivery of Health Care* ; Liver Diseases*; Humans

• Source: Hepatology (Baltimore, Md.) [Hepatology] 2024 Feb 01; Vol. 79 (2), pp. 502-523. Date of Electronic Publication: 2023 Aug 04.Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 8302946 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Validating the new nomenclature of steatotic liver disease in patients with excessive alcohol intake - Authors' reply.

• Authors : Israelsen M; Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark; Institute of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.

Subjects: Fatty Liver* ; Liver Transplantation*; Humans

• Source: The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2024 May; Vol. 9 (5), pp. 409-410.Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101690683 Publication Model: Print Cited Medium: Internet ISSN: 2468-1253

Record details